Bovine Anaplasmosis is also known as gall sickness and is caused by obligate intraerythrocytic bacteria of the order Rickettsiales, family Anaplasmataceae, genus Anaplasma.
Bovine Anaplasmosis occurs in tropical and subtropical regions worldwide, including South and Central America, the USA, southern Europe, Africa, Asia, and Australia.
Diagnosis of bovine anaplasmosis can be done through microscopic examination of stained blood smears using Wright’s stain, New Methylene Blue, Giemsa stain, serological method, polymerase chain reaction (PCR), and post-mortem examination or Necropsy.
Treatment and prevention of bovine anaplasmosis include tetracycline antibiotics and imidocarb, blood transfusions, vaccination, and prevention measures such as insect control, sanitizing needles and instruments between individual animals, and reducing the severity of clinical signs in newly infected animals.
Clinical signs of bovine anaplasmosis include icterus, thin and watery blood, splenomegaly, hepatomegaly with yellow-orange discoloration, and pericardial petechiae.
Transplacental: Spread from the dam to the fetus via the placenta is possible when the dam is infected during the second and third trimesters of pregnancy.
Anaplasmosis starts when the Anaplasma, the causative agent of this disease, infects the herd through the bite of infected insects such as ticks, horse flies, or horn flies.
This will trigger the immune system to develop antibodies to circulating RBCs leading to hemolysis (immune-mediated extravascular hemolysis) or rupture of RBCs.
This happens when the cattle recover from the disease thus, they remain chronically infected carriers but they are generally immune to further clinical disease.
Clinical findings of Bovine Anaplasmosis include all ages of cattle being susceptible, with younger cattle, especially less than 6 months old, rarely exhibiting signs of disease due to rapid and active production of new red blood cells in growing calves.